Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11608-11615

  Sette, Paola ^a   Dussupt, Vincent ^a   Bouamr, Fadila ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIX BRO1 PROTEIN; ALIX PROTEIN; ESCRT PROTEIN; GAG PROTEIN; HOST FACTOR; PROTEIN P66; RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN V;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; VIRUS ATTACHMENT; VIRUS RELEASE;

BINDING SITES; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA, VIRAL; VIRUS RELEASE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84869068775     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01260-12     Document Type: Article

References (45)

1. Adachi A, et al. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284 -291.
2. Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD. 2002.Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev. Cell 3:271-282.
3. Babst M, Odorizzi G, Estepa EJ, Emr SD. 2000. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1:248-258.
4. Bello NF, et al. 2012. Budding of retroviruses utilizing divergent L domains requires nucleocapsid. J. Virol. 86:4182- 4193.
5. Bieniasz PD. 2009. The cell biology of HIV-1 virion genesis. Cell Host Microbe 5:550 -558.
6. Burnett A, Spearman P. 2007. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J. Virol. 81:5000 -5013.
7. Carlton JG, Martin-Serrano J. 2007. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 316:1908-1912.
8. Chen C, Li F, Montelaro RC. 2001. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection. J. Virol. 75:9762-9770.
9. Demirov DG, Freed EO. 2004. Retrovirus budding. Virus Res. 106:87-102.
10. Dussupt V.et al. 2009. The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog. 5:e1000339. doi:10.1371/journal.ppat.1000339.
11. Dussupt V, et al. 2011. Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding. J. Virol. 85:2304-2315.
12. Fisher RD, et al. 2007. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128:841- 852.
13. Fujii K, et al. 2009. Functional role of Alix in HIV-1 replication. Virology 391:284 -292.
14. Garrus JE, et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55- 65.
15. Huang M, Orenstein JM, Martin MA, Freed EO. 1995. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818.
16. Huthoff H, Malim MH. 2007. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and virion encapsidation. J. Virol. 81:3807-3815.
17. Jouvenet N, Simon SM, Bieniasz PD. 2009. Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles.Proc. Natl. Acad. Sci. U.S.A. 106:19114 -19119.
18. Jouvenet N, Zhadina M, Bieniasz PD, Simon SM. 2011. Dynamics of ESCRT protein recruitment during retroviral assembly. Nat. Cell Biol.13:394-401.
19. Katoh K, et al. 2003. The ALG-2-interacting protein Alix associates with CHMP4b, a human homologue of yeast Snf7 that is involved in multivesicular body sorting. J. Biol. Chem. 278:39104 -39113.
20. Khan MA, et al. 2007. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions. Retrovirology 4:48. doi:10.1186/1742-4690-4-48.
21. Kim J, et al. 2005. Structural basis for endosomal targeting by the Bro1 domain. Dev. Cell 8:937-947.
22. Kutluay SB, Bieniasz PD. 2010. Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog. 6:e1001200. doi:10.1371/journal.ppat.1001200.
23. Lee B, Richards FM. 1971. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55:379-400.
24. Li F, Chen C, Puffer BA, Montelaro RC. 2002. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J. Virol. 76:1569-1577.
25. Lu K, Heng X, Summers MF. 2011. Structural determinants and mechanism of HIV-1 genome packaging. J. Mol. Biol. 410:609-633.
26. Martin-Serrano J, Zang T, Bieniasz PD. 2003. Role of ESCRT-I in retroviral budding. J. Virol. 77:4794-4804.
27. McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP. 2008.ALIX-CHMP4 interactions in the human ESCRT pathway. Proc. Natl.Acad. Sci. U.S.A. 105:7687-7691.
28. Montelaro RC, Parekh B, Orrego A, Issel CJ. 1984. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.J. Biol. Chem. 259:10539-10544.
29. Morita E, et al. 2011. ESCRT-III protein requirements for HIV-1 budding.Cell Host Microbe 9:235-242.
30. Morita E, Sundquist WI. 2004. Retrovirus budding. Annu. Rev. Cell Dev.Biol. 20:395- 425.
31. Popov S, Popova E, Inoue M, Gottlinger HG. 2008. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J. Virol. 82:1389 -1398.
32. Rusten TE, Vaccari T, Stenmark H. 2012. Shaping development with ESCRTs. Nat. Cell Biol. 14:38-45.
33. Saff EB, Kuijlaars ABJ. 1997. Distributing many points on a sphere.Mathematical Intelligencer 19:5-11.
34. Schafer A, Bogerd HP, Cullen BR. 2004. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology 328:163-168.
35. Sette P, Jadwin JA, Dussupt V, Bello NF, Bouamr F. 2010. The ESCRT associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J. Virol. 84:8181-8192.
36. Sette P, et al. 2011. The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release. Structure 19:1485-1495.
37. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.Cell 114:689-699.
38. Stuchell-Brereton MD, et al. 2007. ESCRT-III recognition by VPS4 ATPases. Nature 449:740-744.
39. Usami Y, Popov S, Gottlinger HG. 2007. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J. Virol. 81:6614-6622.
40. VerPlank L, et al. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl.Acad. Sci. U.S.A. 98:7724 -7729.
41. von Schwedler UK, et al. 2003. The protein network of HIV budding. Cell 114:701-713.
42. Wei X, et al. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.Antimicrob. Agents Chemother. 46:1896 -1905.
43. Winn MD, et al. 2011. Overview of the CCP4 suite and current developments.Acta Crystallogr. D Biol. Crystallogr. 67:235-242.
44. Zennou V, Perez-Caballero D, Gottlinger H, Bieniasz PD. 2004.APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol. 78:12058 -12061.
45. Zhai Q, et al. 2011. Activation of the retroviral budding factor ALIX. J.Virol. 85:9222-9226.